America's employer-based health insurance system is crumbling. STAT investigates why, in our new series, “Out of Pocket, Out ...
Amy Bielawski is one of the 30 million people who run their own businesses. She's gone most of her life without health ...
Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout ...
Ebola has once again cropped up in Uganda and the Democratic Republic of the Congo. We’ve contained the disease before. But ...
In the past, the possibility of endemic Ebola was unthinkable. This time is different, write Ivan Buendia Gayton and Eric D.
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Read the 5 key takeaways from STAT's series "Out of Pocket, Out of Reach," an examination of workplace health insurance.
Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...
America’s employers must stop acting helpless in the face of health care industry profiteering, Chris Deacon says.
States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, ...
A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical ...
Gen Z physicians are on a collision course with institutions still built around older assumptions,” writes Frantz M. Berthaud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results